Kah Meng Lim
Chief Executive Officer at COMPASS VENTURE INC.
Net worth: 64 800 $ as of 29/11/2023
Profile
Kah Meng Lim is the founder of Gene Oasis Pte Ltd.
He is currently the Chief Executive Officer & Director at Compass Venture, Inc., Chief Executive Officer at Zenzic Labs Pte Ltd., Chief Executive Officer at NGF Bioenterprise Pte Ltd., Director at GDX Corp., Independent Non-Executive Director at Singapore Paincare Holdings Ltd., Director at CanniOasis Pte Ltd., and Director at Betalife Pte Ltd.
Dr. Lim previously worked as an Associate Professor at Tianjin University from 2014 to 2017.
He received his doctorate degree from Yong Loo Lin School of Medicine in 2001.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
COMPASS VENTURE, INC.
7.08% | 25/10/2022 | 400,000 ( 7.08% ) | 64 800 $ | 29/11/2023 |
Kah Meng Lim active positions
| Companies | Position | Start |
|---|---|---|
| COMPASS VENTURE INC. | Chief Executive Officer | 01/01/2019 |
| SINGAPORE PAINCARE HOLDINGS LIMITED | Director/Board Member | 04/03/2021 |
| Zenzic Labs Pte Ltd. | Chief Executive Officer | 31/12/2018 |
| NGF Bioenterprise Pte Ltd. | Chief Executive Officer | 31/12/2016 |
| GDX Corp. | Director/Board Member | 31/12/2018 |
Former positions of Kah Meng Lim
| Companies | Position | End |
|---|---|---|
| Tianjin University | Corporate Officer/Principal | 31/12/2016 |
| Gene Oasis Pte Ltd. | Founder | - |
Training of Kah Meng Lim
| Yong Loo Lin School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SINGAPORE PAINCARE HOLDINGS LIMITED | Health Services |
| Private companies | 5 |
|---|---|
| GDX Corp. | |
| Compass Venture, Inc. | |
| Zenzic Labs Pte Ltd. | |
| NGF Bioenterprise Pte Ltd. | |
| Gene Oasis Pte Ltd. |
- Stock Market
- Insiders
- Kah Meng Lim
